SCHEMBL5195459

SCHEMBL5195459

CC(=O)OCCOc1ccc(C(=O)OCc2ccccc2)c(F)c1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 6/20 0.49
▸ ALDH1A1 P00352 3/20 0.49
▸ L3MBTL1 Q9Y468 3/20 0.48
▸ TDP1 Q9NUW8 2/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ MAOA P21397 1/20 0.47
▸ MEN1 O00255 1/20 0.44
▸ HSP90AA1 P07900 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ MAPT P10636 2/20 0.43
▸ MRGPRX4 Q96LA9 1/20 0.43
▸ POLB P06746 1/20 0.42
▸ PARP15 Q460N3 1/20 0.42
▸ PARP10 Q53GL7 1/20 0.42
▸ RARA P10276 1/20 0.42
▸ RARB P10826 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13267972 0.88 L3MBTL1 (0.64) MAOBALDH1A1L3MBTL1TDP1CYP3A4
SCHEMBL5194892 0.87 ALDH1A1 (0.50) MAOBALDH1A1L3MBTL1TDP1CYP3A4
SCHEMBL2989798 0.86 MAOB (0.57) MAOBALDH1A1L3MBTL1TDP1CYP3A4
SCHEMBL5063445 0.86 ALDH1A1 (0.50) MAOBALDH1A1L3MBTL1TDP1CYP3A4
SCHEMBL5194512 0.85 ALDH1A1 (0.46) MAOBALDH1A1L3MBTL1TDP1CYP3A4
SCHEMBL5193405 0.85 L3MBTL1 (0.50) MAOBALDH1A1L3MBTL1TDP1CYP3A4
SCHEMBL5194255 0.85 MEN1 (0.53) MAOBALDH1A1L3MBTL1TDP1CYP3A4
SCHEMBL5191401 0.85 RARA (0.55) MAOBMAOAMRGPRX4RARARARB
SCHEMBL17700198 0.82 ALDH1A1 (0.51) ALDH1A1L3MBTL1TDP1CYP3A4TSHR
SCHEMBL4841513 0.77 L3MBTL1 (0.65) MAOBALDH1A1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both KISSEI PHARMACEUTICAL CO., LTD. (JP) 2007-10-04 — — US disclosed
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both KISSEI PHARMACEUTICAL CO., LTD. (JP) 2007-10-04 — — US disclosed
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both KISSEI PHARMACEUTICAL CO., LTD. (JP) 2007-10-04 — — US disclosed
EP-1813603-A1 AROMATIC AMIDE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME, MEDICAL USES OF BOTH Kissei Pharmaceutical Co., Ltd. (JP) 2007-08-01 — — EP disclosed
EP-1813603-A1 AROMATIC AMIDE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME, MEDICAL USES OF BOTH Kissei Pharmaceutical Co., Ltd. (JP) 2007-08-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both AVPR2, AVPR1A, AVPR1B MAOB 892/4885ALDH1A1 1557/4885L3MBTL1 2769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback